Question

A 68-year-old woman with heart failure with reduced ejection fraction (HFrEF) and a potassium level of 5.6 mEq/L on a mineralocorticoid receptor antagonist (MRA) asks whether to continue it. What is recommended?

Accepted Answer

Temporarily hold MRA and manage hyperkalemia; consider potassium binders to maintain RAASi

Answer

Continue MRA without changes

Answer

Stop all RAAS-related therapy permanently

Answer

Increase MRA dose

Answer

Switch to verapamil

Practice question

A 68-year-old woman with heart failure with reduced ejection fraction (HFrEF) and a potassium level of 5.6 mEq/L on a mineralocorticoid receptor antagonist (MRA) asks whether to continue it. What is recommended?